Value and mechanisms of home visitation in obesity interventions for low-income children

家访在低收入儿童肥胖干预中的价值及机制

基本信息

  • 批准号:
    9204202
  • 负责人:
  • 金额:
    $ 71.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-02-01 至 2022-01-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Children from low-income families are more than twice as likely to become obese than those from higher- income households, which places them at increased risk for obesity-related chronic diseases throughout their adult lives. Family-based pediatric obesity interventions, particularly those designed for low-income populations, are increasingly delivered in children’s homes. Home visitation has a number of potential advantages that could enhance weight loss outcomes relative to delivering treatment in traditional medical and academic settings. By eliminating the need for transportation and childcare, home visitation may make treatment more accessible for low-income families, resulting in a higher dosage of intervention received. Home visitation allows intervention staff to directly observe and address risk factors in the home environment, potentially enabling them to provide more tailored and potent treatment recommendations. Caregivers may also be more likely to apply healthy changes in their household when they learn and rehearse new skills in the environment where they are to be implemented. Research to date has consistently found that home-based interventions are more effective than low-intensity comparison conditions such as wait-list controls, health education, and usual medical care. Yet, as the home visitation treatment modality has been confounded with intervention dosage, intensity, and content in prior studies, there is a lack of empirical evidence to support its use. The goal of this project is to systematically evaluate the incremental weight loss benefit and cost- effectiveness of delivering standard family-based treatment for pediatric overweight/obesity in the home setting vs. traditional medical settings. In a randomized controlled trial involving low-income households, 266 children ages 6-11 years will be allocated to 12 months of family-based treatment delivered either in their home or at an urban academic medical center. Both arms will receive the same intervention content and dosage, and differ only in the location of in-person treatment sessions. Aim 1 is to test the hypothesis that home-based treatment produces a greater reduction in child adiposity, reflected in 12-month change in BMI z-score. Aim 2 is to compare the cost-effectiveness of home-based treatment to medical center-based treatment, and calculate the added cost of the incremental weight loss benefit associated with home visitation. These data will inform efforts to disseminate home-based interventions for low-income populations by public health agencies and third-party payers. Aim 3 is to explore specific mechanisms through which home visitation may improve weight loss outcomes. The results of this trial will have a strong impact on the design of future pediatric overweight/obesity interventions, as virtually any program could be adapted for delivery in the home setting.
项目摘要/摘要 来自低收入家庭的儿童肥胖的可能性是来自更高的孩子的两倍以上 收入家庭,这使他们在整个过程中都有与肥胖有关的慢性疾病的风险 成人生活。基于家庭的小儿肥胖干预措施,尤其是专为低收入设计 人口越来越多地在儿童家中分配。家庭访问有许多潜力 相对于在传统医学中提供治疗的相对于提供减肥结果的优势, 学术环境。通过消除运输和育儿的需求,家庭探视可能会导致 低收入家庭更容易获得治疗,从而导致收到的干预剂量更高。家 探视使干预人员可以直接观察和解决家庭环境中的风险因素, 潜在的使他们能够提供更量身定制和潜在的治疗建议。照顾者可以 当他们学习和排练新技能时,更有可能在家庭中应用健康的变化 将要实施的环境。迄今为止的研究一直发现家庭基于家庭 干预措施比低强度比较条件(例如等待名单控制,健康状况)更有效 教育和通常的医疗服务。但是,由于家庭访问的治疗方式与 干预剂量,强度和内容在先前的研究中,缺乏经验证据来支持其 使用。该项目的目的是系统地评估增量减肥益处和成本 - 在家庭环境中为小儿超重/肥胖提供标准家庭治疗的有效性 与传统医疗环境。在涉及低收入家庭的随机对照试验中,有266名儿童 6-11岁的年龄将分配给在家中或在家中进行12个月的基于家庭的治疗 城市学术医学中心。两臂都将获得相同的干预内容和剂量,并且不同 仅在面对面治疗会议的位置。目标1是检验基于家庭治疗的假设 在BMI Z分数的12个月变化中,儿童肥胖量的降低较大。目标2是 将基于家庭治疗的成本效益与基于医学中心的治疗进行比较,并计算 与家庭访问相关的增量减肥益处的增加成本。这些数据将为努力提供信息 传播公共卫生机构和第三方低收入人群的家庭干预措施 付款人。目标3是探索家庭探视可以改善体重减轻的特定机制 结果。该试验的结果将对未来的儿科超重/肥胖的设计产生强烈的影响 干预措施,因为几乎任何程序都可以在家庭环境中进行交付。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bradley M. Appelhans其他文献

Neighborhood physical environments and change in cardiometabolic risk factors over 14 years in the study of Women's health across the nation
  • DOI:
    10.1016/j.healthplace.2024.103257
  • 发表时间:
    2024-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Bradley M. Appelhans;Brittney S. Lange-Maia;Chen Yeh;Elizabeth A. Jackson;Mary D. Schiff;Emma Barinas-Mitchell;Carol A. Derby;Carrie A. Karvonen-Gutierrez;Imke Janssen
  • 通讯作者:
    Imke Janssen
Attention Deficit/Hyperactivity Disorder and the Clinical Management of Obesity
注意力缺陷/多动障碍和肥胖的临床管理
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    S. Pagoto;C. Curtin;Bradley M. Appelhans;M. Alonso
  • 通讯作者:
    M. Alonso
Considerations for Interpreting Childhood Obesity Treatment Trials from the COVID-19 Pandemic Era.
解释 COVID-19 大流行时代儿童肥胖治疗试验的注意事项。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Bethany Forseth;Bradley M. Appelhans;Ann M. Davis
  • 通讯作者:
    Ann M. Davis
Psychological Co-morbidities of Cardiovascular Disease
心血管疾病的心理共病
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Whited;Amanda L. Wheat;Bradley M. Appelhans;S. Pagoto
  • 通讯作者:
    S. Pagoto
A point-of-purchase intervention featuring in-person supermarket education impacts healthy food purchases
以现场超市教育为特色的购买点干预措施会影响健康食品的购买
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    B. Milliron;K. Woolf;Bradley M. Appelhans
  • 通讯作者:
    Bradley M. Appelhans

Bradley M. Appelhans的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bradley M. Appelhans', 18)}}的其他基金

Stress, race, and cognitive mediators of SES-related disparities in behavioral obesity treatment outcomes
行为性肥胖治疗结果中与 SES 相关的差异的压力、种族和认知调节因素
  • 批准号:
    10514449
  • 财政年份:
    2022
  • 资助金额:
    $ 71.05万
  • 项目类别:
Stress, race, and cognitive mediators of SES-related disparities in behavioral obesity treatment outcomes
行为性肥胖治疗结果中 SES 相关差异的压力、种族和认知调节因素
  • 批准号:
    10632130
  • 财政年份:
    2022
  • 资助金额:
    $ 71.05万
  • 项目类别:
Delay Discounting and Household Food Choices
延迟折扣和家庭食品选择
  • 批准号:
    8588230
  • 财政年份:
    2013
  • 资助金额:
    $ 71.05万
  • 项目类别:
Delay Discounting and Household Food Choices
延迟折扣和家庭食品选择
  • 批准号:
    8857154
  • 财政年份:
    2013
  • 资助金额:
    $ 71.05万
  • 项目类别:
Neurobehavioral predictors of diet adherence
饮食依从性的神经行为预测因子
  • 批准号:
    7770878
  • 财政年份:
    2009
  • 资助金额:
    $ 71.05万
  • 项目类别:
Neurobehavioral predictors of diet adherence
饮食依从性的神经行为预测因素
  • 批准号:
    7677216
  • 财政年份:
    2009
  • 资助金额:
    $ 71.05万
  • 项目类别:

相似国自然基金

问责制度何以影响地方政府绩效——目标责任制情境下的“问责悖论”研究
  • 批准号:
    71103140
  • 批准年份:
    2011
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Accountability and the Role of the Principal Investigator in Multicenter Trials
多中心试验中首席研究员的责任和作用
  • 批准号:
    8146028
  • 财政年份:
    2010
  • 资助金额:
    $ 71.05万
  • 项目类别:
Accountability and the Role of the Principal Investigator in Multicenter Trials
多中心试验中首席研究员的责任和作用
  • 批准号:
    8549989
  • 财政年份:
    2010
  • 资助金额:
    $ 71.05万
  • 项目类别:
Vascular Medicine at Northwestern University
西北大学血管医学
  • 批准号:
    7233754
  • 财政年份:
    2007
  • 资助金额:
    $ 71.05万
  • 项目类别:
AIDS Malignancy Clinical Trials Consortium
艾滋病恶性肿瘤临床试验联盟
  • 批准号:
    7689546
  • 财政年份:
    2006
  • 资助金额:
    $ 71.05万
  • 项目类别:
AIDS Malignancy Clinical Trials Consortium
艾滋病恶性肿瘤临床试验联盟
  • 批准号:
    7689549
  • 财政年份:
    2006
  • 资助金额:
    $ 71.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了